By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
The pharmaceutical industry has used nanoparticle formulations for decades to increase bioavailability and enable consistent dosing.
Similarly, high-pressure homogenization enables the cannabinoid formulators to manufacture cannabinoid nanoparticle formulations both at R&D scale and consumer scale. These nanoparticle cannabinoids have the potential to increase the efficacy while creating longer-lasting and more stable cannabinoid products.
